These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33274945)
1. Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2. Peng C; Zhu Z; Shi Y; Wang X; Mu K; Yang Y; Zhang X; Xu Z; Zhu W J Phys Chem Lett; 2020 Dec; 11(24):10482-10488. PubMed ID: 33274945 [TBL] [Abstract][Full Text] [Related]
2. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk. Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769 [TBL] [Abstract][Full Text] [Related]
3. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
4. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation. Rui L; Haonan L; Wanyi C Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377 [TBL] [Abstract][Full Text] [Related]
5. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2. Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655 [TBL] [Abstract][Full Text] [Related]
7. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor. Sitthiyotha T; Chunsrivirot S Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401 [TBL] [Abstract][Full Text] [Related]
8. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2. Nguyen K; Chakraborty S; Mansbach RA; Korber B; Gnanakaran S Viruses; 2021 May; 13(5):. PubMed ID: 34067878 [TBL] [Abstract][Full Text] [Related]
9. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1. Yajima H; Anraku Y; Kaku Y; Kimura KT; Plianchaisuk A; Okumura K; Nakada-Nakura Y; Atarashi Y; Hemmi T; Kuroda D; Takahashi Y; Kita S; Sasaki J; Sumita H; ; Ito J; Maenaka K; Sato K; Hashiguchi T Nat Commun; 2024 Oct; 15(1):8574. PubMed ID: 39375326 [TBL] [Abstract][Full Text] [Related]
11. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Jena AB; Kanungo N; Nayak V; Chainy GBN; Dandapat J Sci Rep; 2021 Jan; 11(1):2043. PubMed ID: 33479401 [TBL] [Abstract][Full Text] [Related]
13. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor. Treewattanawong W; Sitthiyotha T; Chunsrivirot S Sci Rep; 2021 Nov; 11(1):22202. PubMed ID: 34772947 [TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2. Dash P; Turuk J; Behera SK; Palo SK; Raghav SK; Ghosh A; Sabat J; Rath S; Subhadra S; Rana K; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Dash S; Parida A; Pati S Int J Infect Dis; 2021 Mar; 104():491-500. PubMed ID: 33450373 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
16. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability. Verma J; Subbarao N Virology; 2021 Sep; 561():107-116. PubMed ID: 34217923 [TBL] [Abstract][Full Text] [Related]
17. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein. Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984 [TBL] [Abstract][Full Text] [Related]
18. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480 [TBL] [Abstract][Full Text] [Related]
19. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Xu C; Wang Y; Liu C; Zhang C; Han W; Hong X; Wang Y; Hong Q; Wang S; Zhao Q; Wang Y; Yang Y; Chen K; Zheng W; Kong L; Wang F; Zuo Q; Huang Z; Cong Y Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33277323 [TBL] [Abstract][Full Text] [Related]
20. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants. Sang P; Chen YQ; Liu MT; Wang YT; Yue T; Li Y; Yin YR; Yang LQ Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]